Target lesion located in the left main stem
STEMI
Restenosis
Cardiogenic shock
Malignancies or other comorbid conditions with life expectancy less than 12 months or that may result in protocol noncompliance
Known allergy to the study medications (probucol, sirolimus, zotarolimus)
Pregnancy (present, suspected, or planned)

NCT03026465_exc_T1
Condition
Target lesion
NCT03026465_exc_T2
Qualifier
left main stem
NCT03026465_exc_T3
Condition
STEMI
NCT03026465_exc_T4
Condition
Restenosis
NCT03026465_exc_T5
Condition
Cardiogenic shock
NCT03026465_exc_T6
Condition
Malignancies
NCT03026465_exc_T7
Condition
comorbid conditions
NCT03026465_exc_T8
Qualifier
other
NCT03026465_exc_T9
Observation
life expectancy
NCT03026465_exc_T10
Value
less than 12 months
NCT03026465_exc_T11
Observation
protocol noncompliance
NCT03026465_exc_T12
Mood
may
NCT03026465_exc_T13
Scope
life expectancy less than 12 months or that may result in protocol noncompliance
NCT03026465_exc_T14
Scope
Malignancies or other comorbid conditions
NCT03026465_exc_T15
Condition
allergy
NCT03026465_exc_T16
Drug
study medications
NCT03026465_exc_T17
Drug
probucol
NCT03026465_exc_T18
Drug
sirolimus
NCT03026465_exc_T19
Drug
zotarolimus
NCT03026465_exc_T20
Scope
probucol, sirolimus, zotarolimus
NCT03026465_exc_T21
Condition
Pregnancy
NCT03026465_exc_T22
Temporal
present
NCT03026465_exc_T23
Mood
suspected
NCT03026465_exc_T24
Mood
planned
NCT03026465_exc_T25
Scope
present, suspected, or planned